Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT®
QUEBEC CITY, April 6, 2023 /PRNewswire/ -- Icentia Inc., today announced that it has received FDA 510(k) clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that relies
United States United Kingdom Pierre Paquet Prnewswire Icentia Inc Icentia Inc Stroke Awareness Foundation
Source: finanznachrichten.de